NPI: 1336529577 · SUFFOLK, VA 23434 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/03/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/03/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,764 | $80K |
| 2019 | 15,579 | $226K |
| 2020 | 15,145 | $260K |
| 2021 | 16,028 | $209K |
| 2022 | 14,231 | $228K |
| 2023 | 5,068 | $257K |
| 2024 | 708 | $12K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 23,374 | 1,472 | $1.25M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 23,237 | 1,027 | $18K |
| A4657 | Syringe, with or without needle, each | 3,823 | 1,227 | $7K |
| J1756 | Injection, iron sucrose, 1 mg | 5,357 | 1,005 | $818.13 |
| G0008 | Administration of influenza virus vaccine | 87 | 57 | $399.59 |
| J1270 | Injection, doxercalciferol, 1 mcg | 11,405 | 760 | $147.89 |
| 90674 | 41 | 25 | $113.15 | |
| 83970 | 641 | 425 | $45.84 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,194 | 408 | $20.48 |
| 82728 | 479 | 323 | $10.84 | |
| 85041 | 1,223 | 824 | $7.91 | |
| 83550 | 493 | 324 | $7.43 | |
| 85048 | 1,226 | 825 | $6.78 | |
| 82108 | 434 | 294 | $6.63 | |
| 83540 | 493 | 324 | $5.50 | |
| 86706 | 16 | 14 | $0.00 |